Replies to post #715535 on NorthWest Biotherapeutics Inc (NWBO)

[StonkMaster]

I don't disagree. But as we know, the SP doesn't always reflect what shareholders believe the company is truly worth.

If we trade at $3 post approval (pre-NICE reimbursement) that would be roughly a 4B MC for a relatively small market. I don't think that's unrealistic at all.

To be clear, I'm not saying I think that's the ceiling.